Literature DB >> 12016429

Nonalcoholic fatty liver disease.

Jeanne M Clark1, Frederick L Brancati, Anna Mae Diehl.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12016429     DOI： 10.1053/gast.2002.33573

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  225 in total

1.  Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C.

Authors:  Sekou R Rawlins; Ola El-Zammar; J Michael Zinkievich; Nancy Newman; Robert A Levine
Journal:  Dig Dis Sci       Date:  2010-05-12       Impact factor: 3.199

2.  Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Jau-Chung Hwang; Hung Chiang; Chi-Yang Chang; Ching-Tai Lee; Ming-Lung Yu; Jaw-Town Lin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

3.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

4.  Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.

Authors:  Paola Loria; Amedeo Lonardo; Francesca Leonardi; Cristina Fontana; Lucia Carulli; Anna Maria Verrone; Andrea Borsatti; Marco Bertolotti; Fabio Cassani; Alberto Bagni; Paolo Muratori; Dorval Ganazzi; Francesco B Bianchi; Nicola Carulli
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

5.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

6.  Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

Authors:  Aliya Qayyum; Daryl M Chen; Richard S Breiman; Antonio C Westphalen; Benjamin M Yeh; Kirk D Jones; Ying Lu; Fergus V Coakley; Peter W Callen
Journal:  Clin Imaging       Date:  2009 Mar-Apr       Impact factor: 1.605

7.  Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Authors:  Savino Bruno; Patrick Maisonneuve; Paola Castellana; Nicole Rotmensz; Sonia Rossi; Marco Maggioni; Marcello Persico; Alberto Colombo; Franco Monasterolo; Donata Casadei-Giunchi; Franco Desiderio; Tommaso Stroffolini; Virgilio Sacchini; Andrea Decensi; Umberto Veronesi
Journal:  BMJ       Date:  2005-03-03

Review 8.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

Review 9.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

10.  Dietary composition and nonalcoholic fatty liver disease.

Authors:  Steven Solga; Amir R Alkhuraishe; Jeanne M Clark; Mike Torbenson; Ashli Greenwald; Anna Mae Diehl; Thomas Magnuson
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.